Loading stock data...

Fabino Life Sciences Limited

BSE: FABINO

BSE
26.00 0.00 (0.00%)

Prev Close

26

Open Price

26

Volume

3,000

Today Low / High

26 / 26

52 WK Low / High

22.8 / 38.96

Range

25 - 27

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 26, reflecting a change of 0 (0%). The expected target range on the BSE is 25 - 27. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

08 Aug 26.00 0.00%

Fabino Life Sciences Limited Graph

Fabino Life Sciences Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Fabino Life Sciences Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 26.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 26.00 26.26 23.63 - 28.89
26.52 21.22 - 31.82
26.78 18.75 - 34.81
Bearish Scenario 26.00 25.74 23.17 - 28.31
25.48 20.38 - 30.58
25.22 17.65 - 32.79

Overview of Fabino Life Sciences Limited

ISIN

INE0DRT01018

Industry

Medical - Pharmaceuticals

Vol.Avg

15,600

Market Cap

54,600,000

Last Dividend

0

Official Website

Visit Website

IPO Date

2024-12-30

DCF Diff

N/A

DCF

0

Financial Ratios Every Investor Needs

Stock Rating Details for FABINO

Metric Value Recommendation
Overall Rating D+ Strong Sell
DCF Score 1 Strong Sell
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 2 Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 18.04 Cr 16.49 Cr 1.55 Cr 0.0858 0.00 Cr 0.00 Cr 0.03 Cr 0.06 Cr 0.28 0.40 Cr 0.0034
2024-03-31 21.08 Cr 20.05 Cr 1.03 Cr 0.0488 0.00 Cr 0.00 Cr 0.08 Cr 0.04 Cr 0.17 0.13 Cr 0.0017
2023-03-31 3.36 Cr 2.95 Cr 0.41 Cr 0.1220 0.00 Cr 0.04 Cr -0.01 Cr 0.01 Cr 0.05 0.05 Cr 0.0032
2022-03-31 4.20 Cr 3.58 Cr 0.62 Cr 0.1480 0.00 Cr 0.07 Cr 0.07 Cr 0.05 Cr 0.22 0.10 Cr 0.0112
2021-03-31 3.06 Cr 2.73 Cr 0.32 Cr 0.1058 0.00 Cr 0.01 Cr 0.05 Cr 0.03 Cr 0.14 0.06 Cr 0.0099

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 0.24 Cr 17.66 Cr 13.45 Cr 4.2080 Cr 1.79 Cr 1.55 Cr 1.20 Cr 0.55 Cr 0.00 Cr 0.00 Cr 0.00 Cr 11.6622 Cr
2024-03-31 0.06 Cr 15.36 Cr 11.21 Cr 4.1442 Cr 1.27 Cr 1.21 Cr 1.33 Cr 0.34 Cr 0.00 Cr 0.00 Cr 0.00 Cr 9.8985 Cr
2023-03-31 0.24 Cr 5.01 Cr 0.90 Cr 4.1146 Cr 0.41 Cr 0.16 Cr 1.19 Cr 0.15 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.4451 Cr
2022-03-31 0.59 Cr 4.62 Cr 0.52 Cr 4.1038 Cr 0.05 Cr -0.54 Cr 1.71 Cr 0.17 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.4096 Cr
2021-03-31 0.07 Cr 2.25 Cr 0.95 Cr 1.3027 Cr 0.31 Cr 0.24 Cr 0.47 Cr 0.16 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.5553 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 0.1234 Cr -0.4186 Cr 0.4769 Cr -0.1656 Cr 0.1818 Cr 0.2438 Cr -0.2890 Cr 0.1880 Cr 0.5219 Cr 0.0000 Cr 0.1317 Cr
2024-03-31 -0.7682 Cr -0.2753 Cr 0.8630 Cr -1.0059 Cr -0.1805 Cr 0.0620 Cr -0.2377 Cr 0.0358 Cr 0.8630 Cr 0.0000 Cr -0.1474 Cr
2023-03-31 -0.6752 Cr -0.0107 Cr 0.3396 Cr -0.6819 Cr -0.3464 Cr 0.2425 Cr -0.0067 Cr 0.0108 Cr 0.3596 Cr 0.0000 Cr 0.5217 Cr
2022-03-31 -1.8988 Cr -0.0496 Cr 2.4717 Cr -1.9445 Cr 0.5233 Cr 0.5889 Cr -0.0457 Cr 0.0470 Cr -0.2623 Cr 0.0000 Cr -1.2405 Cr
2021-03-31 -0.4499 Cr -0.1004 Cr 0.4474 Cr -0.5437 Cr -0.1029 Cr 0.0655 Cr -0.0938 Cr 0.0302 Cr -0.0876 Cr 0.0000 Cr -0.1743 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2024-09-30 2.13 Cr 1.83 Cr 0.30 Cr 0.1390 0.24 Cr 0.01 Cr 0.07 0.07 Cr 0.0066
2024-06-30 2.13 Cr 1.83 Cr 0.30 Cr 0.1390 0.24 Cr 0.01 Cr 0.07 0.07 Cr 0.0066
2024-03-31 4.11 Cr 3.96 Cr 0.16 Cr 0.0379 -0.04 Cr -0.03 Cr -0.12 0.00 Cr -0.0064
2023-12-31 4.11 Cr 3.96 Cr 0.16 Cr 0.0379 -0.04 Cr -0.03 Cr -0.12 0.00 Cr -0.0064
2023-09-30 6.43 Cr 6.20 Cr 0.23 Cr 0.0360 0.19 Cr 0.04 Cr 0.21 0.07 Cr 0.0068

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 0.24 Cr 0.00 Cr 0.24 Cr 15.58 Cr 1.20 Cr 17.03 Cr 0.55 Cr 17.66 Cr 13.45 Cr
2024-09-30 0.04 Cr 0.00 Cr 0.04 Cr 14.46 Cr 3.45 Cr 19.78 Cr 0.33 Cr 20.20 Cr 16.03 Cr
2024-06-30 0.04 Cr 0.00 Cr 0.04 Cr 14.46 Cr 3.45 Cr 19.78 Cr 0.33 Cr 20.20 Cr 16.03 Cr
2024-03-31 0.06 Cr 0.00 Cr 0.06 Cr 13.53 Cr 1.33 Cr 14.93 Cr 0.34 Cr 15.36 Cr 11.21 Cr
2023-12-31 0.06 Cr 0.00 Cr 0.06 Cr 12.61 Cr 1.33 Cr 14.93 Cr 0.34 Cr 15.36 Cr 11.21 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2024-09-30 0.01 Cr -0.53 Cr -0.05 Cr 0.56 Cr 0.00 Cr 0.00 Cr 0.00 Cr -0.01 Cr -0.54 Cr
2024-06-30 0.01 Cr -0.53 Cr -0.05 Cr 0.56 Cr 0.00 Cr 0.00 Cr 0.00 Cr -0.01 Cr -0.54 Cr
2024-03-31 -0.03 Cr -0.43 Cr -0.14 Cr 0.09 Cr 0.00 Cr 0.00 Cr 0.00 Cr -0.12 Cr -0.55 Cr
2023-12-31 -0.03 Cr -0.43 Cr -0.14 Cr 0.09 Cr 0.00 Cr 0.00 Cr 0.00 Cr -0.12 Cr -0.55 Cr
2023-09-30 0.04 Cr 0.04 Cr 0.00 Cr 0.35 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.04 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹821.25 ₹98,339,283,675.00 ₹72,992.00

Key Executives

Chief Financial Officer
Mr. Pankaj Jain

Gender: male

Year Born:

Company Secretary & Compliance Officer
Ms. Kanchi Gehlot

Gender: female

Year Born:

FAQs about Fabino Life Sciences Limited

Who is the CEO of the company?

The CEO is Pankaj Jain.

What is the current market price of the stock?

The current price is ₹26.00.

What is the 52-week price range?

The range is ₹22.8-38.96.

What is the market capitalization of the company?

The market capitalization is ₹5.46 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 3,121.68.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Fabino Life Sciences Limited (ISIN: INE0DRT01018) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹5.46 crores and an average daily volume of 15,600 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.

Welcome to the Investing and Trading Information platform: InvesTrack.in

Note: This platform is for educational and informational purposes only. Do not consider anything as financial advice.

QUICK LINKS

Home
About us
Contact us
Privacy Policy
Disclaimer
Sitemap
Investing
Trading
Top Brokers
Tools
Live Analysis

STAY CONNECTED

Follow Us On Social Media
Get Latest Update On Social Media
Facebook Instagram Twitter

General Disclaimer: InvesTrack is an educational platform and not any type of investment advisory platform. Our Blog and videos are based on countless hours of research and experience, which you can use as a guide for your research purposes. None of our content should be considered a piece of investment advice. Earning Disclosure: InvesTrack is a community supported platform. We may earn a commission when you make a purchase through one of our links at no extra cost to you. Note: We are not SEBI Registered Advisors. This website is purely for training and educational purposes. We shall not be responsible for your profit or loss.

© Copyright 2024 - 2025 | InvesTrack